Skip to main content
. 2019 May 10;39(5):BSR20182161. doi: 10.1042/BSR20182161

Figure 1. SNAI1 expression is required for tube formation in vitro.

Figure 1

(A–D) TDECs were under different treatments and tested for neoangiogenesis by tube formation assay. (E–H) Tube formation was performed with different treatments in TDECs. Cells were transiently transfected with SNAI1 siRNA (siSNAI1) at a concentration of 50 nM and scrambled siRNA (luciferase) was used as a negative control. Otherwise, TDECs were transiently transfected with pCMV-SNAI1 at a concentration of 50 nM or control (pCMV). (I) Quantitation of tube formation in indicated conditions in all five donors-derived TDECs were shown. Data are present with means ± S.D. *P<0.05.